Bringing you the latest news, trends, and insight circulating the global pharmaceutical development and manufacturing industry.
UK + USA
Joined February 2009
- Tweets10.9K
- Following573
- Followers17.2K
- Likes119
PharmTech Group retweeted
Our latest survey of #biopharma professionals on #DigitalTransformation in the industry uncovered a hype-actual adoption gap.
Get the full industry report at lnkd.in/eeSbk4ba
#AI
PharmTech Group retweeted
Latest survey of professionals in bio/#Pharmaceutical industry garnered ~90 completions that reveal the profound impact on operations and supply chains! Dive into the full survey results here: pharmtech.com/view/biopharma…
#supplychainsecurity #BioPharma #Tariffs #SupplyChain #Biotech
PharmTech Group retweeted
Regular contributors Dr. Pluta, Alan Mancini, @RooseveltU's Dr. Thakar & @UICPharm's Dr. Chaiyaperm offer a detailed, ordered process for compounding #pharmaceutical dosage forms in #503A pharmacies, #503B outsourcing, #pharma, and other work environments pharmtech.com/view/dosage-fo…
PharmTech Group retweeted
Discover current trends, identify key strategies to accelerate early-phase development, share approaches to speeding up timelines for even the most complex formats, and look into the future of advancements in large-molecule manufacturing.
Register now: hubs.li/Q03w5DqY0
PharmTech Group retweeted
EMA's Executive Steering Group on Shortages and Safety of Medicinal Products has issued recommendations to address vulnerabilities in the supply chain of anti-D immunoglobulins. hubs.li/Q03wKZvY0
PharmTech Group retweeted
Hydrogels, drug-eluting contact lenses, and other implant technologies show real promise for delivery of ocular therapies. hubs.li/Q03vHRV_0
PharmTech Group retweeted
9 Implications of #Trump’s Tax-Cut and Spending Bill for the #Bio/#Pharmaceutical Industry pharmtech.com/view/9-implica…
#BigBeautifulBill #Biopharmaceutical #pharma
PharmTech Group retweeted
SMC gave positive opinions to four medicines beside the one from Theramex, while refusing to issue recommendations for three others.
hubs.li/Q03w4Z6w0
PharmTech Group retweeted
Check out the latest Ask the Expert episode where Simona Guidi of ProPharma discusses the options available for controlling adventitious contamination in cell processing and the use of closed processing systems for cell therapy production.hubs.li/Q03tNTk60
PharmTech Group retweeted
"Though the biopharmaceutical industry has successfully implemented [continuous] processes for drug substance, its application for drug product manufacturing is still nascent,” - Paresh Vadgama, Fellow Scientist at Catalent. Read more from @PharmTechGroup: ow.ly/CkUg50NG3he
PharmTech Group retweeted
Kerstin Pohl, senior manager of #GeneTherapy and Nucleic Acid here on #TeamSCIEX, discusses the impact of some of these changes with Jill Murphy in @PharmTechGroup 👇 bit.ly/3Hz8Mjt
PharmTech Group retweeted
Listen to the @PharmTechGroup #podcast with our CTO, David Bunka, to learn about the potential of #Optimer binders in #drugdelivery, including targeting capabilities, scalability, and differences between Optimer and #antibody-drug conjugates (#ADC). pharmtech.com/view/drug-solu…
PharmTech Group retweeted
Check out this article on @PharmTechGroup titled "6 Approaches Making the Most Significant Impact in the Future" where our CSO, Dr. Nicholas Geisse, speaks on one way Curi Bio utilizes AI/ML to accelerate research.
Read the article: hubs.ly/Q01yFkQ40
PharmTech Group retweeted
Advanced CDS are one of the most important innovations to help #pharma organizations meet dynamic #regulatory requirements while also increasing operational efficiency. Read more in our latest article with @PharmTechGroup: ow.ly/SVw150MbF9g
PharmTech Group retweeted
Lab automation comes in many forms, and the way #labs choose to automate can have a big impact on their throughput and agility.
Our VP of Product, Nick Pattinson, spoke with @PharmTechGroup about the benefits of automating entire lab #workflows.
bit.ly/3WcRRtb
PharmTech Group retweeted
[ALA Client in the News] Brian Mullan, CTO at @yposkesi, an SK pharmteco company, recently wrote an article for @PharmTechGroup
Brian shares his insights on 'Choosing the Right CDMO for CGT Programs'👇
pharmtech.com/view/choosing-…
#CDMO #genetherapy
PharmTech Group retweeted
In an era of patient-centric drug design, how can the industry adapt?
Read this article in @PharmTechGroup’s latest eBook to discover our insights into why small is a powerful ingredient for patient-centric formulations: e-digitaleditions.com/i/1481…
#smallispowerful
PharmTech Group retweeted
Listen to CEO, Andrew Scharenberg, MD, and CTO, Ryan Crisman, PhD, of our client @UmojaBiopharma on the latest episode of @PharmTechGroup's Drug Solutions Podcast: bit.ly/3xFkqou
PharmTech Group retweeted
How can we navigate the challenges to achieve a brighter future for patients?
Listen to this @PharmTechGroup podcast to hear insights from our CCO @ChristianDJones into empowering a new era of patient-centric medicines: pharmtech.com/view/empowerin… #smallispowerful
PharmTech Group retweeted
More than 25% of drugs worldwide are formulated with highly potent APIs, and 60% of those are cancer therapies. Our #SmallMolecules expert David Lyon spoke with @PharmTechGroup about addressing several HPAPI formulation challenges.
Read more here: bit.ly/3dss6DB
